InvestorsHub Logo
icon url

georgejjl

02/27/24 9:12 PM

#452881 RE: Steady_T #452880

Anavex 3-71 could and should be FDA approved for the treatment of schizophrenia as the result of the data from the Phase 2 trial.

Good luck and GOD bless,
Bullish
Bullish
icon url

sumbuysumsell

02/27/24 10:51 PM

#452885 RE: Steady_T #452880

That's right.

So add 5 years to the end of the P2 for the appropriate P3 trial to be completed. Does that put things into 2030 minimum?